Identity
- Security key
- 23466
- Ticker
- VRXA
- Type
- CS — Common Stock
- Exchange
- Nasdaq(XNAS)
- Venue group
- NASDAQ
- Operating MIC
- XNAS
- Market
- stocks
- Locale
- us
- Currency
- USD
- Listed
- 2026-06-11
- Round lot
- 100
- Active
- Yes
- Last seen in a load
- 2026-08-14 20:49
- Vendor updated
- 2026-08-13 06:09
- Ticker root / suffix
- VRXA
Detail
Enriched 2026-08-14 20:47
- Market cap
- $267,260,766.57
- Shares outstanding (class)
- —
- Shares outstanding (weighted)
- 141,407,813
- SIC
- —
- Employees
- —
- Location
- —
- Homepage
- https://www.veraxa.com
- Description
Veraxa Biotech Holding AG focus on antibody therapies in medicine. The Company is an oncology-focused biotechnology Company with a clinical program in acute myeloid leukemia and two proprietary platform technologies that enable the development of new generations of antibody drug conjugates (ADC's) and T cell engagers. The Company operates in one reportable segment, focused on the research and development of products for the aging population.
Market cap and share counts drift.